
At PharmSci 360, Insilica CEO Thomas Luechtefeld will present on auditable agentic AI systems and how they are expanding computational toxicology beyond single predictive models.
By Jim Erickson, Blue Mountain Quality Resources, Inc., pp. 63-64. In the fast-paced biopharmaceutical manufacturing environment, "speed to market" is the hallmark catch phrase. Many companies are focusing only on the processes that add the most value and are outsourcing the rest. This focus on core competencies has some biotech companies reevaluating their calibration practices. Many are contracting more of that workload, from both laboratory and production facilities, to calibration service laboratories.
over 24 years ago
Outsourcing Outlook: Reaping the Benefits of E-Procurementover 24 years ago
The Immunogenicity of Therapeutic Proteinsover 24 years ago
Inside Washington: Costs and Controls Challenge Manufacturersover 24 years ago
21 CFR Part 11: (Un)Expected Added Value